FIELD: medicine.
SUBSTANCE: invention includes a compound with the following formula:
, where R represents a linear oligophosphoric acid residue, as well as its use as an agent for inhibiting platelet aggregation.
EFFECT: production of new antiplatelet agents that have the ability to irreversibly inhibit platelet functions.
2 cl, 5 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCE, IRREVERSIBLY DEPRESSING FUNCTIONS OF PLATELETS | 2017 |
|
RU2675630C1 |
| SUBSTANCE INHIBITING FUNCTIONS OF PLATELETS | 2008 |
|
RU2382764C1 |
| COMPOUND REACTING WITH THIOL CLUSTER OF ATOMS AND INHIBITING THROMBOCYTE FUNCTION | 2010 |
|
RU2452727C1 |
| AGENT FOR INHIBITION OF PLATELET ACTIVITY | 1998 |
|
RU2161483C2 |
| METHOD FOR REDUCING AGGREGATION ABILITY OF PLATELETS | 2021 |
|
RU2751964C1 |
| METHOD OF EVALUATING THE EFFECTIVENESS OF NON-AGGREGATE PREPARATIONS AFFECTING THE METABOLISM OF ARACHIDONIC ACID BY INHIBITION OF CYCLOOXYGENASE-1 BOTH INDIVIDUALLY AND JOINTLY WITH ADP P2Y RECEPTOR ANTAGONIST ON PLATELET MEMBRANES OF THE BLOOD TO THE PATIENT RECEIVING NON-AGGREGATE PREPARATIONS | 2010 |
|
RU2442167C1 |
| METHOD OF TREATMENT OF STATES ACCOMPANYING WITH PLATELET HYPERAGGREGATION | 1997 |
|
RU2150943C1 |
| NITROESTER OF OXIDIZED STARCH SODIUM SALT SHOWING ANTIAGGREGANT ACTION | 1991 |
|
RU2074195C1 |
| 2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
| PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
